Nefazodone attenuates the behavioral and neurochemical effects of ethanol

Alcohol

Volumn 15, Issue 1, 1998, Pages 77-86

  Olausson, Peter ^a   Ericson, Mia ^a   Petersson, Annelie ^a   Kosowski, Alexander ^a   Söderpalm, Bo ^a   Engel, Jörgen A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Dopamine; Ethanol; Ethanol intake; In vivo microdialysis; Nefazodone; Rat; Serotonin

Indexed keywords

NEFAZODONE; SEROTONIN 2A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; DOPAMINE BRAIN LEVEL; DRUG EFFECT; MALE; NONHUMAN; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030635276     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(97)00101-8     Document Type: Article

References (69)

1. 1. Abacus Concepts.: StatView Abacus Concepts Inc., Berkeley CA, 1992:319-332.
2. 2. Balldin, J.; Berggren, U.; Engel, J.; Eriksson, M.; Hård, E.; Söderpalm, B.: Effect of citalopram on alcohol intake in heavy drinkers. Alcohol. Clin. Exp. Res. 18(5):1133-1137; 1994.
3. 3. Benloucif, S.; Keegan, M. J.; Galloway, M. P.: Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther. 265:373-377; 1993.
4. 4. Blomqvist, O.; Engel, J. A.; Nissbrandt, H.; Söderpalm, B.: The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Eur. J. Pharmacol. 249:207-213; 1993.
5. 5. Blomqvist, O.; Söderpalm, B.; Engel, J. A.: Ethanol-induced locomotor activity: Involvement of central nicotinic acetylcholine receptors? Brain Res. Bull. 29:173-178; 1992.
6. 6. Brodie, M. S.; Trifunovic, R. D.; Shefner, S. A.: Serotonin potentiates ethanol-induced excitation of ventral tegmental area neurons in brain slices from three different rat strains. J. Pharmacol. Exp. Ther. 273:1139-1146; 1995.
7. 2 receptors. Soc. Neurosci. Abstr. 21:1702; 1995.
8. 8. Campbell, A. D.; McBride, W. J.: Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. Pharmacol. Biochem. Behav. 51(4):835-842; 1995.
9. 3 receptor antagonists block morphine-and nicotine-but not amphetamine-induced reward. Psychopharmacology (Berlin) 97:175-178; 1989.
10. 2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse-implications for psychosis. J. Neural Transm. 100:225-237, 1995.
11. 11. Chandler, L. J.; Sumners, C.; Crews, F. T.: Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol. Clin. Exp. Res. 17(1):54-60; 1993.
12. 12. Collins, D. M.; Myers, R. D.: Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol 4:49-56; 1987.
13. 2 receptor antagonist, ritanserin. J. Neurochem. 59:1459-1466; 1992.
14. 14. Eison, A. S.; Eison, M. S.; Torrente, J. R.; Wright, R. N.; Yocca, F. D.: Nefazodone: Preclinical pharmacology of a new antidepressant. Psychopharmacol. Bull. 6(3):311-315; 1990.
15. 15. Engel, J. A.: Neurochemical aspects of the euphoria induced by dependence-producing drugs. In: Ideström, C.-M., ed. Recent advances in the study of alcoholism. Amsterdam: Excerpta Medica International Congress Series 407; 1977:16-22.
16. 16. Engel, J. A.; Enerback, C.; Fahlke, C.; Hulthe, P.; Hård, E.; Johannessen, K.; Svensson, L.; Söderpalm, B.: Serotonergic and dopaminergic involvement in ethanol intake. In: Naranjo, C. A.; Sellers, E. M., eds. Novel pharmacological interventions for alcoholism. New York: Springer-Verlag; 1992:68-82.
17. 17. Engel, J. A.; Fahlke, C.; Hulthe, P.; Hård, E.; Johannessen, K.; Snape, B.; Svensson, L.: Biochemical and behavioural evidence for an interaction between ethanol and calcium channel antagonists. J. Neural Transm. 74:181-193; 1988.
18. 18. Fahlke, C.: Alcohol consumption in the rat. Thesis, Göteborg University, Sweden; 1994.
19. 19. Gold, L. H.; Balster, R. L.: Evaluation of nefazodone self-administration in rhesus monkeys. Drug Alcohol Depend. 28:241-247; 1991.
20. 20. Guan, X.-M.; McBride, W. J.: Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens. Brain Res. Bull. 21:43-46; 1988.
21. 21. Guan, X.-M.; McBride, W. J.: Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23:541-547; 1989.
22. 22. Heidbreder, C.; De Witte, P.: Ethanol differentially affects extracellular monoamines and GABA in the nucleus accumbens. Pharmacol. Biochem. Behav. 41:477-481; 1993.
23. 23. Hemrick-Luecke, S. K.; Snoddy, H. D.; Fuller, R. W.: Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo. Life Sci. 55(7):479-483; 1994.
24. 24. Hervé, D.; Pickel, V. M.; Joh, T. H.; Beaudet, A.: Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res. 435:71-83; 1987.
25. 25. Hurd, Y. L.; Ungerstedt, U.: In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate putamen. Eur. J. Pharmacol. 166:251-260; 1989.
26. 26. Ichikawa, J.; Meltzer, H. Y.: Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens. J. Neurochem. 58:2285-2291; 1992.
27. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett. 101:214-217; 1989.
28. 28. Imperato, A.; Di Chiara, G.: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats. J. Pharmacol. Exp. Ther. 239:219-228; 1986.
29. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res. 513:156-160; 1990.
30. 30. Kalivas, P. W.: Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:75-113; 1993.
31. 2A antagonist MDL 100,907 on stimulant-enhanced locomotion in rats. Soc. Neurosci. Abstr. 19:666.13; 1993.
32. 3 receptors in the rat brain using radioligand binding. Nature 330:746-748; 1987.
33. 33. Kranzler, H. R.; Burleson, J. A.; del Boca, F. K.; Babor, T. F.; Korner, P.; Brown, J.; Bonn, M. J.: Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Arch. Gen. Psychiatry 51(9):720-731; 1994.
34. 34. LeMarquand, R.; Pihl, R. O.; Benkelfat, C.: Serotonin and alcohol intake, abuse, and dependence: Clinical evidence. Biol. Psychiatry 36:326-337; 1994.
35. 35. LeMarquand, R.; Pihl, R. O.; Benkelfat, C.: Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies. Biol. Psychiatry 36:395-421; 1994.
36. 36. Martel, P.; Fantino, M.: Mesolimbic dopaminergic system activity as a function of food reward: A microdialysis study. Pharmacol. Biochem. Behav. 53(1):221-226; 1996.
37. 2 antagonists amperozide and trazodone on preference for alcohol in rats. Alcohol 11(3):203-206; 1994.
38. 38. Meert, T.; Awouters, F.; Niemegeers, C. J. E.; Schellekens, K. H. L.; Janssen, P. A. J.: Ritanserin reduces abuse of alcohol, cocaine and fentanyl in rats. Pharmacopsychiatry 24:159-163; 1991.
39. 39. Mirenowicz, J.; Schultz, W.: Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 379:449-451; 1996.
40. 40. Moghaddam, B.; Bunney, B. S.: Ionic composition of microdialysis perfusion solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem. 53:652-654; 1989.
41. 41. Myers, R. D.: New drugs for the treatment of experimental alcoholism. Alcohol 11(6):439-451; 1994.
42. 2 antagonist amperozide. Alcohol 10:117-125; 1993.
43. 2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats. Pharmacol. Biochem. Behav. 45: 233-237; 1993.
44. 44. Nissbrandt, H.; Waters, N.; Hjorth, S.: The influence of serotonergic drugs on dopaminergic transmission in rat substantia nigra and limbic forebrain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 346:12-19; 1992.
45. 45. Nomikos, G. G.; Iurlo, M.; Andersson, J. L.; Kimura, K.; Svensson, T. H.: Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology (Berlin) 115:147-156; 1994.
46. 3 mediated control of dopaminergic function. Psychopharmacology (Berlin) 112(Suppl. 1):60-67; 1993.
47. 47. Panocka, I.; Ciccocioppo, R.; Polidori, C.; Massi, M.: The nucleus accumbens is a site of action for the inhibitory effect of ritanserin on ethanol intake in rats. Pharmacol. Biochem. Behav. 46:857-862; 1993.
48. 3H]5-hydroxytryptamine. Neuroscience 6:115-138; 1981.
49. 49. Parsons, L. H.; Justice, J. B., Jr.: Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:195-199; 1993.
50. 50. Paxinos, G.; Watson, C.: The rat brain in stereotaxic coordinates, 2nd ed. Sydney: Academic Press; 1986.
51. 51. Pazos, A.; Cortes, R.; Palacios, R. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346:231-249; 1985.
52. 52. Pazos, A.; Palacios, R. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346:205-230; 1985.
53. 2A receptors in antipsychotic activity. Life Sci. 56:2209-2222; 1995.
54. 54. Serra, G.; DAquila, P. S.; Gessa, G. L.: Role of the mesolimbic system in the mechanism and action of antidepressants. Pharmacol. Toxicol. 71(Suppl. 1):72-85; 1992.
55. 3 receptor antagonist, on A9 and A10 dopamine neurons. Eur. J. Pharmacol. 163:115-118; 1989.
56. 2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis. J. Pharmacol. Exp. Ther. 260(2):872-878; 1992.
57. 57. Steinbusch, H. W. M.: Distribution of serotonin-immunoreactivity in the central nervous system of the rat cell-bodies and terminals. Neuroscience 6(4):557-618; 1981.
58. 58. Suzdak, P. D.; Schwartz, R. D.; Skolnick, P.; Paul, S. M.: Ethanol stimulates GABA receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc. Natl. Acad. Sci. USA 83:4071-4075; 1986.
59. 59. Svensson, L.; Engel, J. A.; Hård, E.: Effects of the 5-HT receptor agonist, 8-OH-DPAT, on ethanol preference in the rat. Alcohol 6:17-21; 1989.
60. 60. Svensson, L.; Fahlke, C.; Hård, E.; Engel, J. E.: Involvement of the serotonergic system in ethanol intake in the rat. Alcohol 10:219-224; 1993.
61. 61. Tanda, G.; Carboni, E.; Frau, R.; Di Chiara, G.: Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential? Psychopharmacology (Berlin) 115:285-288; 1994.
62. 62. Trifunovic, R. D.; Brodie, M. S.: The effects of clomipramine on excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro. J. Pharmacol. Exp. Ther. 276:34-40; 1996.
63. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology (Berlin) 98:45-50; 1989.
64. 64. VanderMaelen, C. P.; Braselton, J. P.: Effects of the antidepressant compound nefazodone on central monoaminergic neuronal discharge in rats. Drug Dev. Res. 25:235-247; 1992.
65. 3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study. Eur. J. Pharmacol. 242:151-163; 1993.
66. 66. Willner, P.: Dopaminergic maehanisms in depression and mania. In: Bloom, F. E.; Kupfer, D. J., eds. Psychopharmacology: The fourth generation of progress. New York; Raven Press; 1995:921-931.
67. 67. Wise, R. A.; Rompre, P.-P.: Brain dopamine and reward. Ann. Rev. Psychol. 40:191-225; 1989.
68. 3 receptors attenuates the effects of ethanol on extracellular dopamine. Eur. J. Pharmacol. 187:287-289; 1990.
69. 69. Yoshimoto, K.; McBride, W. J.; Lumeng, L.; Li, T.-K.: Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 9:17-22; 1991.